Skip to content

Cerebellar stimulation to treat refractory epilepsy in children

Cerebellar stimulation to treat refractory epilepsy in children

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22556
Enrollment
9
Registered
2019-10-30
Start date
2018-10-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory epilepsy

Interventions

Electrical stimulation of the brain via implanted leads

Sponsors

Erasmus MC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Refractory epilepsy for at least one year, with a seizure frequency of at least four per month. • Failure of at least three adequately tried AED regimens, as determined by the principal investigator, including ketogenic diet if appropriate. • Age 4 – 18 years at time of inclusion. The first 3 patients are at least 7 years old. • Definite diagnosis of epilepsy syndrome as reported by treating clinician according to international standards and confirmed by recruitment team. • Written informed consent of parents/caretakers.

Exclusion criteria

Exclusion criteria: • Other progressive neurologic or medical diseases. • Evident co-existing non-epileptic seizures. • Candidate for resective epilepsy surgery. • Inability to complete neuropsychological tests or complete seizure diaries by caretakers. • Vagal nerve stimulators in situ. • Surgical contraindications such as coagulation disorders. • Contraindications for MRI. • Anatomical abnormalities of skull and posterior fossa, precluding safe lead placement and fixation. • Immune deficiency. • Insufficient space or subcutaneous fat to safely implant stimulator.

Design outcomes

Primary

MeasureTime frame
To determine the efficacy of cerebellar stimulation in children with refractory epilepsy by measuring number and severity of seizures.

Secondary

MeasureTime frame
To determine safety and long term effects of (intermittent-) continuous cerebellar stimulation by monitoring number of adverse events, cognitive development, and effects on daily life and behavior.

Contacts

Public ContactW Busser

Erasmus MC

w.busser@erasmusmc.nl+31 (0)10 70 43507

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)